Zelira Therapeutics has signed a five-year deal with Health House International to distribute its SprinjeneCBD toothpaste brand in the UK.
Zelira managing director Dr Oludare Odumosu said: “Zelira took a very strategic position in the cannabinoid-based consumer product segment with the successful launch of our first SprinjeneCBD oral care toothpaste product in the US.
“Health House International has established distribution networks in emerging markets such as the UK, and will be a key channel as we continue to grow our global distribution footprint.”
The distribution agreement expands the availability of the SprinjeneCBD toothpaste brand beyond the US and into the UK, a market it said represents “significant growth opportunities for clinically validated, hemp-derived oral care products”.
